EPISODE · Sep 8, 2023 · 33 MIN
New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD
from HCPLive Podcasts · host HCPLive.com
Host Veeral Sheth, MD is joined by Megan Baldwin, PhD, CEO and Managing Director of Opthea Limited, to discuss OPT-302 or sozinibercept, the company's novel anti-VEGF-C / VEGF-D treatment for wet AMD and other retinal diseases.Episode Highlights:0:06 Introduction0:37 Background of Dr. Baldwin9:56 Promising data on OPT-302/sozinibercept16:39 Making decisions as a clinician, industry leader22:11 Future of the treatment landscape28:24 What’s next for Opthea?32:39 ConclusionPlease direct any podcast-related inquiries to [email protected].
NOW PLAYING
New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m